Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review.
Dermatol Online J
; 27(10)2021 Oct 15.
Article
in En
| MEDLINE
| ID: mdl-35130383
ABSTRACT
The prevalence of telogen effluvium (TE) has increased during COVID-19. In this study we describe the clinical characteristics of patients with COVID-19-related TE and review the current literature on COVID-19-associated TE. We conducted a retrospective chart review of 66 patients, all of which had COVID-19 infection (confirmed by PCR or antibodies) and had either non-scarring hair loss or TE in Elmhurst, Queens. Our data suggest that this form of TE is similar to other forms of TE, after which many patients experience regrowth within several months.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Alopecia
/
COVID-19
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
America do norte
Language:
En
Journal:
Dermatol Online J
Year:
2021
Document type:
Article